Related Experiment Video
Updated: Aug 17, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
Published on: March 10, 2015
Transmissible spongiform encephalopathy risk assessment: the UK experience
1Department of Theoretical Biology, Faculty of Biological Sciences, University of South Bohemia, Branisovska 31, 37005 Ceske Budejovice, Czech Republic. e.grist@rhul.ac.uk
Abstract:
Transmissible spongiform encephalopathy (TSE) risk assessments undertaken in the United Kingdom have mainly had the objective of determining the risks posed to humans from exposure to the causal agents associated with bovine spongiform encephalopathy (BSE) and variant Creutzfeld-Jakob disease (vCJD). In this article, I examine 19 of these risk assessments published to date and consider how their results might be influenced by underlying model assumptions and methodology. Three separate aspects common to all the assessments are infective load estimation, exposure pathway identification, and risk estimation. These are each discussed in detail.
Related Concept Videos
Toxoplasmosis
Investigation of Disease Outbreaks
Rocky Mountain Spotted Fever
Arboviral Encephalitis

